Drs. Carrie Houts, Mike Edwards, and R.J. Wirth from VPG and Linda Deal, from Pfizer, published a literature review in Quality of Life Research entitled “A review of empirical research related to the use of small quantitative samples in clinical outcome scale development.”
Dr. R.J. Wirth, VPG President and Managing Partner, has been elected Co-Chair of the ISOQOL Psychometric Special Interest Group. He will take over as Chair-elect this October in Copenhagen at the ISOQOL annual meeting.
This blog entry takes a look at measuring athleticism in NFL tight ends. VPG’s A2B™ effectively characterizes 4 unique TE Player Types and quantifies NFL potential based on athletic profiles. Our analyses indicated that athletic characteristics explained about 18% of the variability in NFL performance for tight ends. The A2B™ indicates that there are a handful of 2016 TEs that have athletic ability that should transfer well to the NFL. Development of the A2B™ for TEs The A2B™ classifies tight … Read More
Dr. R.J. Wirth will be attending ISOQOL’s Measuring What Matters Symposium on July 25-26 in Washington, DC. Check out our back cover ad in the Measuring What Matters program.
VPG’s Drs. Wirth, Edwards, and Houts have teamed with members of Johnson and Johnson Vision Care, Inc. to develop the Contact Lens User Experience: CLUE assessment system. There is a link to the paper on our News Blog.